NuCannaCo Science Limited FPO

NCS0.300
  • CHANGE
    0.00%
  • LAST
    0.3
  • VOLUME
    10000
  • LAST TRADE
    13-Nov-2017 2:54:33 PM

Annual Statements for NuCannaCo Science Limited (NCS)

31-Dec
2017
31-Dec
2016
AUD AUD
REVENUE
Interest Received71
Total Revenue25,807
Cost of sales
Gross Profit
EXPENSES
Administration Expenses(50,000)
Travel Expenses(11,332)(74,516)
Employee Benefits Expense(800,531)
Share based payments(1,449,159)
Amortisation and impairments(763,398)
Professional Expenses(4,681)(24,544)
IPO Fees/Startup costs(313,771)(276,526)
Auditor Remuneration(87,306)(28,000)
Management fees(141,667)(16,000)
Exchange Gains/Losses unrealised(7,950)
Investment Gain/Loss(188,143)
Other Expenses(325,638)(1,756,553)
Total Expenses(2,694,417)(3,625,298)
PROFIT / (LOSS)
Profit/Loss before income tax(2,668,610)(3,625,298)
Profit/Loss after income tax(2,668,610)(3,625,298)
Foreign Exchange Gain/(Loss) on Translation of Foreign Ops1,805
Total Comprehensive Income(2,666,805)(3,625,298)
ASSETS
Current Assets
Cash and Cash Equivalents1,092778
Trade and Other Receivables30,976
Prepayments8,154
Inventories22,253
Other Current Assets121,548
Other Investments410,000
Total Current Assets472,475122,326
Non-Current Assets
Deposits held6,029
Total Non-Current Assets6,029
Total Assets478,504122,326
LIABILITIES
Current Liabilities
Trade and other payables1,228,617370,291
Total Current Liabilities1,228,617370,291
Non-Current Liabilities
Total Liabilities1,228,617370,291
NET ASSETS(750,113)(247,965)
EQUITY
Issued Capital4,105,3321,940,675
Reserves1,438,4631,436,658
Contributed Equity(6,293,908)(3,625,298)
Total Equity(750,113)(247,965)
CASH FLOW
Net Cash provided by (used in) operating activities(1,062,756)(308,813)
Net Cash provided by (used in) investing activities525,848
Net Cash provided by (used in) financing activities537,222309,591
Net Increase (decrease) in cash held314778
Cash at the beginning of the period778
Cash at the end of the period1,092778